The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021.
Shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, and huge burden of varicose vein cases in North America and Europe is driving the growth of the market.
Other growth factors include improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.
For More Information, Request PDF brochure: www.marketsandmarkets.com/pdfdownload.asp?id=22524107
However, dearth of training for vascular surgeons, high cost of varicose vein treatment procedures, and implementation of healthcare reforms in the U.S.are some of the key factors restraining the growth of this market.
In addition to this, challenges associated with inconsistent reimbursement scenario for varicose vein treatment procedures and sustainability of players in the highly competitive market also limits the growth of the market.
This report broadly segments the varicose vein treatment market into mode of treatment and products. On the basis of mode of treatment, the market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping.
The endovenous ablation segment is expected to command the major share of the market, by mode of treatment, in 2016.
Based on type of products, the varicose vein treatment market is segmented into ablation devices, venous closure products, and surgical products. The ablation devices segment is further categorized into radiofrequency ablation devices and laser ablation devices.
In 2016, the radiofrequency ablation devices segment is expected to command the major share of the ablation devices market for varicose vein treatment.
This report covers the varicose vein treatment market across two major geographies, namely, North America and Europe. In this report, the North American market is further segmented into the U.S.
and Canada, while the European varicose vein treatment market is categorized into Germany, U.K., France, Italy, Spain, and Rest of Europe. In 2016, North America is expected to command the largest share of the market in North America and Europe.
However, Europe is expected to register the highest growth rate during the forecast period from 2016 to 2021, due to increasing adoption of advanced treatment procedures and favorable government initiatives in this region.
Major players in the varicose vein treatment market include Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd.
(Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc.
(U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.), among others
Category: Market Research Publishers and RetailersCompany about: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...
For more information: